American Portfolios Advisors - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$432,450
+0.9%
31,000
-0.1%
0.02%0.0%
Q2 2022$428,593
-15.6%
31,035
-0.5%
0.02%
+5.9%
Q1 2022$507,543
+0.0%
31,195
+0.2%
0.02%0.0%
Q4 2021$507,352
+9.7%
31,1450.0%0.02%0.0%
Q3 2021$462,503
-25.8%
31,145
-0.2%
0.02%
-29.2%
Q2 2021$622,964
-13.5%
31,195
-0.0%
0.02%
-22.6%
Q1 2021$720,211
+185.7%
31,205
+205.8%
0.03%
+138.5%
Q4 2020$252,064
-46.2%
10,205
-9.7%
0.01%
-51.9%
Q3 2020$468,705
-14.0%
11,305
-0.7%
0.03%
-25.0%
Q2 2020$545,216
-22.0%
11,380
+2.5%
0.04%
-37.9%
Q1 2020$699,171
-52.6%
11,105
-6.7%
0.06%
-44.8%
Q4 2019$1,475,020
+99.3%
11,903
+6.7%
0.10%
+72.1%
Q3 2019$740,246
-16.6%
11,1550.0%0.06%
-18.7%
Q2 2019$887,603
+7457.3%
11,155
+10523.8%
0.08%
+7400.0%
Q1 2019$11,745
+11.0%
1050.0%0.00%0.0%
Q4 2018$10,583
-49.2%
105
-36.4%
0.00%
-50.0%
Q3 2018$20,849
-87.7%
165
-91.8%
0.00%
-91.3%
Q2 2018$169,498
+405.5%
2,020
+270.6%
0.02%
+360.0%
Q1 2018$33,528
-1.9%
545
-6.8%
0.01%0.0%
Q4 2017$34,1765850.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders